Quoin Pharmaceuticals Ltd
QNRX
Company Profile
Business description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Contact
42127 Pleasant Forest Court
AshburnVA20148-7349
USAT: +1 703 980-4182
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
4
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,403.70 | 24.00 | 0.29% |
CAC 40 | 7,409.11 | 58.74 | 0.80% |
DAX 40 | 19,254.97 | 177.43 | 0.93% |
Dow JONES (US) | 42,052.19 | 288.73 | 0.69% |
FTSE 100 | 8,177.15 | 67.05 | 0.83% |
HKSE | 20,460.24 | 46.19 | -0.23% |
NASDAQ | 18,239.92 | 144.77 | 0.80% |
Nikkei 225 | 38,053.67 | 1,027.58 | -2.63% |
NZX 50 Index | 12,584.79 | 25.51 | 0.20% |
S&P 500 | 5,728.80 | 23.35 | 0.41% |
S&P/ASX 200 | 8,144.20 | 25.40 | 0.31% |
SSE Composite Index | 3,264.42 | 7.60 | -0.23% |